These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27084254)
41. Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim. Bussel JB; Wang X; Lopez A; Eisen M Hematology; 2016 May; 21(4):257-62. PubMed ID: 26251926 [TBL] [Abstract][Full Text] [Related]
42. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study. Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447 [TBL] [Abstract][Full Text] [Related]
43. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. Tuckuviene R; Christensen AL; Helgestad J; Johnsen SP; Kristensen SR J Pediatr; 2011 Oct; 159(4):663-9. PubMed ID: 21596390 [TBL] [Abstract][Full Text] [Related]
44. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Palandri F; Polverelli N; Sollazzo D; Romano M; Catani L; Cavo M; Vianelli N Am J Hematol; 2016 Jun; 91(4):E267-72. PubMed ID: 26799593 [TBL] [Abstract][Full Text] [Related]
45. Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study. Ekstrand C; Bahmanyar S; Cherif H; Kieler H; Linder M Cancer Epidemiol; 2020 Dec; 69():101806. PubMed ID: 32947155 [TBL] [Abstract][Full Text] [Related]
46. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953 [TBL] [Abstract][Full Text] [Related]
47. Association of primary immune thrombocytopenia and common allergic diseases among children. Chiang MR; Wei CC; Muo CS; Fu LS; Li TC; Kao CH Pediatr Res; 2015 Apr; 77(4):597-601. PubMed ID: 25580738 [TBL] [Abstract][Full Text] [Related]
48. Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura. Newland A Eur J Haematol Suppl; 2009 Mar; (71):20-5. PubMed ID: 19200304 [TBL] [Abstract][Full Text] [Related]
49. Pharmacoepidemiology of Immune Thrombocytopenia: protocols of FAITH and CARMEN studies. Moulis G; Sailler L; Adoue D; Lapeyre-Mestre M Therapie; 2014; 69(5):437-48. PubMed ID: 25285364 [TBL] [Abstract][Full Text] [Related]
51. Use of romiplostim for primary immune thrombocytopenia in children. Escudero Vilaplana V; Aragonés JH; Fernández-Llamazares CM; Bieler CB; Rodríguez SM; Sáez MS Pediatr Hematol Oncol; 2012 Mar; 29(2):197-205. PubMed ID: 22376020 [TBL] [Abstract][Full Text] [Related]
52. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388 [TBL] [Abstract][Full Text] [Related]
53. Risk factors and characteristics of ischemic stroke in patients with immune thrombocytopenia: A retrospective cohort study. Rong X; Jiang L; Qu M; Yang S; Wang K; Jiang L J Stroke Cerebrovasc Dis; 2022 Oct; 31(10):106693. PubMed ID: 36054971 [TBL] [Abstract][Full Text] [Related]
54. Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura. Xue F; Wentworth C; Ganesh V; Gastanaga V; Stryker S; Cha S; Zhao S Am J Hematol; 2011 Sep; 86(9):738-42. PubMed ID: 21786287 [TBL] [Abstract][Full Text] [Related]
55. Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. Huang CE; Chen YY; Chang JJ; Kuan FC; Lee KD; Lu CH; Lung J; Shen CH; Chen CC Hematology; 2017 Jan; 22(1):54-60. PubMed ID: 27396368 [TBL] [Abstract][Full Text] [Related]
56. Passive immune thrombocytopenia in neonates of mothers with idiopathic thrombocytopenic purpura: incidence and risk factors. Yamada H; Kato EH; Kobashi G; Kishida T; Ebina Y; Kaneuchi M; Suzuki S; Fujimoto S Semin Thromb Hemost; 1999; 25(5):491-6. PubMed ID: 10625208 [TBL] [Abstract][Full Text] [Related]
57. Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP. Antel KR; Panieri E; Novitzky N S Afr Med J; 2015 Apr; 105(5):408-12. PubMed ID: 26242673 [TBL] [Abstract][Full Text] [Related]
58. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362 [TBL] [Abstract][Full Text] [Related]
59. Comorbidities in patients with persistent or chronic immune thrombocytopenia. Enger C; Bennett D; Forssen U; Fogarty PF; McAfee AT Int J Hematol; 2010 Sep; 92(2):289-95. PubMed ID: 20652840 [TBL] [Abstract][Full Text] [Related]
60. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]